Filter
333
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
38
New Publications
114
Language
Document type
No document type
186
Guidelines
53
Studies & Reports
40
Strategic & Response Plan
20
Manuals
18
Fact sheets
6
Training Material
5
Situation Updates
4
Infographics
1
Countries / Regions
Kenya
18
Uganda
14
India
13
Western and Central Europe
13
Nigeria
12
Ghana
11
Eastern Europe
11
Global
11
Nepal
9
South Africa
9
Ethiopia
8
Namibia
8
Rwanda
7
Sierra Leone
6
Malawi
6
Tanzania
5
South–East Asia Region
5
Liberia
4
Congo, Democratic Republic of
4
Zambia
4
Cambodia
4
Bangladesh
4
West and Central Africa
4
Zimbabwe
3
Lesotho
3
East and Southern Africa
3
Latin America and the Carribbean
3
Africa
3
Russia
3
Senegal
2
Philippines
2
Syria
2
Indonesia
2
Mozambique
2
Sudan
2
Benin
2
Eswatini/ Swaziland
2
Ukraine
2
Botswana
2
Madagascar
2
Myanmar / Burma
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Cameroon
1
Haiti
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Thailand
1
Gambia
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Bhutan
1
Laos
1
Georgia
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
164
Clinical Guidelines
44
Public Health
11
Capacity Building
6
Women & Child Health
6
Pharmacy & Technologies
4
Key Resources
2
Toolboxes
TB
44
Pharmacy
37
AMR
28
COVID-19
22
HIV
16
NTDs
13
NCDs
4
Ebola
3
Refugee
2
Specific Hazards
2
Caregiver
2
Cholera
1
Polio
1
Rapid Response
1
Global Health Education
1
Planetary Health
1
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us
...
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clinical development of a vaccine. 2. Ensur
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global
...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra
...
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care;
...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of
...
first issued 18 August 2022
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines
...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол
...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach
...
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions
...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren
...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities
...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
